Filana Therapeutics (FLNA) Cash & Equivalents (2010 - 2026)
Filana Therapeutics' Cash & Equivalents came in at $82.68 million for Q2 2026, down 26.4% from $112.38 million a year earlier and down 4.5% from the prior quarter.
Powered by 
Analysis
Filana Therapeutics (FLNA) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, Filana Therapeutics' Cash & Equivalents was $95.5 million, down 25.7% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of 0.4% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $128.57 million in FY2024 (+6.1%), $121.14 million in FY2023 (-39.7%), $201.02 million in FY2022 (-13.9%) and $233.44 million in FY2021 (+149.6%).
- The Q2 2026 figure represents the lowest quarterly Cash & Equivalents since Q3 2020.
- Year-over-year, Cash & Equivalents has declined for six consecutive quarters, with an average decline of 18.5% over the last eight quarters.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q3 2021 (growth of 903.3%), and the weakest in Q2 2025 (a decline of 45.8%).
- Business Quant data shows FLNA's Cash & Equivalents at $86.57 million (Q1 2026), $95.5 million (Q4 2025) and $106.08 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Filana Therapeutics | 30.92 Mn | -339.92 Mn | - | 82.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 82.68 Mn |
| Mar 31, 2026 | 86.57 Mn |
| Dec 31, 2025 | 95.50 Mn |
| Sep 30, 2025 | 106.08 Mn |
| Jun 30, 2025 | 112.38 Mn |
| Mar 31, 2025 | 117.33 Mn |
| Dec 31, 2024 | 128.57 Mn |
| Sep 30, 2024 | 148.98 Mn |
| Jun 30, 2024 | 207.29 Mn |
| Mar 31, 2024 | 124.17 Mn |
| Dec 31, 2023 | 121.14 Mn |
| Sep 30, 2023 | 142.35 Mn |
| Jun 30, 2023 | 168.44 Mn |
| Mar 31, 2023 | 187.47 Mn |
| Dec 31, 2022 | 201.02 Mn |
| Sep 30, 2022 | 174.66 Mn |
| Jun 30, 2022 | 197.23 Mn |
| Mar 31, 2022 | 209.69 Mn |
| Dec 31, 2021 | 233.44 Mn |
| Sep 30, 2021 | 241.52 Mn |
API Access
Filana Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=FLNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "FLNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=FLNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();